Recent Posts
- Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors
- NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand
- Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
Archives
-
Dr Alejandra Bruna joins Cycle Group Holdings Board of DirectorsApril 29th, 2021 -
-
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors
- NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand
- Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
Recent Tweets
-
Check out this collection of #avada #Foodie prebuilt sites bit.ly/33DgVzE Infinitely customizable to suit… twitter.com/i/web/status/1…
1 day ago -
The ins & outs of image optimization for your website can be a relatively complex subject. However, it does not nee… twitter.com/i/web/status/1…
1 day ago -
@MukeshVishnoi Thank you for letting us know. We are working our way through the submitted applications as a matter of priority.
1 day ago
Recent Comments